Brompheniramine, codeine, and phenylephrine and Ibritumomab Intravenous
Determining the interaction of Brompheniramine, codeine, and phenylephrine and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / codeine / phenylephrine
Brand name: M-End PE, Poly-Tussin AC, TL-Hist CD
Synonyms: n.a.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brompheniramine, codeine, and phenylephrine-Ibritumomab Tiuxetan
- Brompheniramine, codeine, and phenylephrine-Ibrutinib
- Brompheniramine, codeine, and phenylephrine-Ibrutinib Capsules
- Brompheniramine, codeine, and phenylephrine-Ibrutinib Tablets
- Brompheniramine, codeine, and phenylephrine-Ibu
- Brompheniramine, codeine, and phenylephrine-IBU Tablets
- Ibritumomab Intravenous-Brompheniramine, Codeine, and Phenylephrine Liquid
- Ibritumomab Intravenous-Brompheniramine, codeine, and pseudoephedrine
- Ibritumomab Intravenous-Brompheniramine, dextromethorphan, and phenylephrine
- Ibritumomab Intravenous-Brompheniramine, dextromethorphan, and pseudoephedrine
- Ibritumomab Intravenous-Brompheniramine, dextromethorphan, guaifenesin, and phenylephrine
- Ibritumomab Intravenous-Brompheniramine, hydrocodone, and pseudoephedrine